chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse concerning a 13 year old male who on 03-AUG-2010 was vaccinated with GARDASIL (lot # not reported) on her left arm and MENACTRA on unspecified arm. On 06-AUG-2010 the patient's parent called into the office and stated that sometime after receiving GARDASIL on 03-AUG-2010 the patient experienced swelling of the lymph node under her left and right arms, but there was more swelling under the left arm than the right arm. Unspecified medical attention was sought. At the time of the report, the outcome of the event was unknown. Follow-up information has been received from a certified medical assistant (previously reported as a nurse) concerning a 13 year old male with no illness and pre-existing medical conditions who on 03-AUG-2010 was vaccinated IM in the left deltoid with the first dose of GARDASIL (lot # 666929/0331Z) and IM in the left deltoid with the first dose of MENACTRA. On 04-AUG-2010, the patient developed pain in both in axilla post receiving vaccine. Pain was developed approximately 24 hours post injection. Noted 3 "quarter sized" swollen, tender lumps under left arm approximated 48 hours post vaccine. Pain and swelling improved over following 2 days and were gone by 07-AUG-2010. No fever, fatigue, rash, headache. There were no diagnostic tests performed. Additional information is not expected.
No fever, rash on both legs, rt arm whelps, no vomiting or diarrhea; Rash began to appear 48hrs p/vax adm; rx DPH;
Patient presented to the ED @ c/p sharp pain across her pelvis and down left leg + SOB/chest tightness. Was given a cardio workup with insignificant findings/normal EKG. CT of chest/neck presented an enlarged thyroid. Patient has made an appointment with ENT. Patient reports vaccination x 3rd dose of Moderna Covid 19 vaccine earlier in the day 3 November.  VAERS filed.
pt went limp & pale & was acting as if was in shock; mom blew in pts face; to hosp WBC was elevated 18,000; MD felt it was hypotonic spell D/T immun t102.6; lethargic;
Swelling in right arm post receiving VARICELLA vaccine.  Swelling & reddness began 4/29/09.  Tx'd with XYZAL 5 mg daily.  Was already on MINOCYCLINE for another DX.
Couldn't walk for 10 days without holding on to furniture; This case was reported by a consumer via media and described the occurrence of walking difficulty in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included denosumab (Prolia) for product used for unknown indication.   Previously administered products included Shingles vaccine (1st dose received on an unknown date).   On an unknown date, the patient received the 1st dose of Shingles vaccine and Prolia at an unknown dose and frequency. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced walking difficulty. On an unknown date, the outcome of the walking difficulty was recovered/resolved.   It was unknown if the reporter considered the walking difficulty to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient stated that he/she had first vaccine and then it was replaced with the one that was used now. The patient received Shingles vaccine and experienced very bad side effects from first injection and could not walk for 10 days without holding on to furniture. The case was reported to pharmacy and food and drug administration, The pharmacy and doctor said that the patient was not to get second injection. It was unknown if the reporter considered the walking difficulty to be related to Prolia. The follow up would not be possible as no contact details were available. Note: It was unknown if the patient received Prolia before/with/after Shingles vaccine, hence was conservatively captured as suspect. The clarification has been raised for the same.
Pt stated that her lips were tingling and numb, and that she felt lightheaded about 20 min after getting her 2nd dose. After about 5 minutes the symptoms improved.
he was giving some misgivings; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION ERROR (he was giving some misgivings) in a 74-year-old patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (he was giving some misgivings). At the time of the report, PRODUCT ADMINISTRATION ERROR (he was giving some misgivings) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       No concomitant medication was reported. The dosage text was reported as unknown. The patient had a total of 6 Moderna, 2 original, 2 bivalent and 2 mRNA. Patient reported that their doctor when they saw them in October they were due now and he was giving some misgivings.  It was reported that the mRNA temporary interferes with interferons and leaving an individual in a vulnerable situation with any other infections. No treatment medication was reported.
Tinnitus in the right ear, that did not improve after the second shot and has not gone away almost 9 months later. I also had the typical short-term side effects like fatigue and sore arm, but those went away within 2 days
Profuse bleeding from nose. On and off heavy bleeding X 5 hours. Went to ED. Emergency visit to ENT next day for cauterization
Localized swelling and pain- reddened area approx size of a softball with welping at injection site.
No additional AE; Inappropriate schedule of vaccine administered; Caller reporter improperly stored and administered vaccines for MMR-II, PROQUAD, and VARIVAX to multiple patients since May 2023 (TE occurred 5/9/2023). No symptoms reported. Caller did not have specific AE information available regarding patient inf; This spontaneous report was received from other and refers to a 14-year-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 06-JUN-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, lot #W001518, expiration date: 13-JAN-2024, administered for prophylaxis (strength, and route of administration were not provided); and  varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #W020540, expiration date: 28-JUN-2024, administered for prophylaxis (strength, and route of administration were not provided) (Inappropriate schedule of product administration). This vaccine underwent temperature excursion before administration in 58.65 degree Farenheit (F) for 25 hours 45 minutes (Product storage error). No additional adverse event was reported.
Swollen red rash 3 inches by 1.5 inches left tricep area.
High fever, chills, diarrhea, weakness, dizziness. Supportive care, Tylenol.
received the first dose 12 years ago; This spontaneous report as received from a physician refers to a 30 year old female patient. Information about concurrent condition, concomitant medication and medical history was not provided.   In approximately 2009 (reported as 12 years ago), the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) for prophylaxis. She did not complete the series (Inappropriate schedule of vaccine administered).
This spontaneous report was received from a healthcare worker refers to a multiple unspecified patients of unknown age and gender. There was no information about concurrent condition, medical history or concomitant medications. On an unknown dates, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # L037561 and expiry date 29-SEP-2017) (dosing details unspecified). No adverse effects were reported. No Product Quality Complaint (PQC) was involved. Details of temperature excursion: Temperature: Ranging from -14.9c to -9.8c for 30 to 31 minute increments from 01-MAR-2016 through 15-MAR-2016. Previous temperature excursion: No. Data logger in use: No, possible malfunctioning thermometer. This is one of the two reports received from the same reporter. Additional information has been requested.
Malaise; Headache; This case was reported by a consumer via call center representative and described the occurrence of malaise in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st October 2019, the patient received Shingrix. On 1st November 2019, 1 days after receiving Shingrix, the patient experienced malaise and headache. On an unknown date, the outcome of the malaise and headache were unknown.   It was unknown if the reporter considered the malaise and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but could be between 70 or 71 years. The patient reported having a malaise and a headache the day after receiving Shingrix. The patient did not consent to follow up.
7 x 5 cm red, tender, indurated right thigh and extremely fussy.  After applying ice and administering Tylenol, induration 4x 4 cm and less fussy.
Pt w/ PMH significant for Migraines, Asthma, Allergic Rhinitis, GERD, Cervical Spondylosis, Genital Herpes, HLD, and chronic back/neck/shoulder pain. 15mins post vaccination, pt c/o difficulty breathing and chest tightness.  Vitals: BP 145/83, HR 80, RR 20, SpO2 99% -- > 127/73, 71, 18 Pt was observed for an additional 15mins in a quiet area.  MD gave the pt the ok to go home w/ a friend.  Pt left w/ a steady gait.  No known allergies  Current medications: Albuterol 90mcg/act 2inh TID PRN Wheezing or SOB ciclesondie 80mcg/act 1inh BID cetirizine 10mp PO daily dramamine unknown dose/frequency lidocaine 5%patch  Apply to affected areas BID
swelling of lips; fever blisters; cracking of the upper lip; tremors in the kneecap, arms started shaking and shaking everywhere; was barely able to walk; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (tremors in the kneecap, arms started shaking and shaking everywhere), GAIT DISTURBANCE (was barely able to walk), LIP SWELLING (swelling of lips), ORAL HERPES (fever blisters) and CHAPPED LIPS (cracking of the upper lip) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Road traffic accident and Accident automobile. Concomitant products included GABAPENTIN, CARBAMAZEPINE and CLONAZEPAM for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced TREMOR (tremors in the kneecap, arms started shaking and shaking everywhere) and GAIT DISTURBANCE (was barely able to walk). On an unknown date, the patient experienced LIP SWELLING (swelling of lips), ORAL HERPES (fever blisters) and CHAPPED LIPS (cracking of the upper lip). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and LORAZEPAM at an unspecified dose and frequency. At the time of the report, TREMOR (tremors in the kneecap, arms started shaking and shaking everywhere), GAIT DISTURBANCE (was barely able to walk), LIP SWELLING (swelling of lips), ORAL HERPES (fever blisters) and CHAPPED LIPS (cracking of the upper lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications included Benadryl and Lorazepam.
FEVER,FEELING WEAK,HEADACHE,CHILLS. INJECTION SITE TO  LEFT ARM FEELS SOREAND HAD EPISODE OF NUMBNESS TO LEFT ARM  PER RN 07/17/07 AT 1256
MODERNA COVID VACCINE 3RD DOSE GIVEN 12/30/21, LOT #013H21B; pt to ED with worsening SOB x 1 wk; found to be positive for COVID; placed on BiPAP; AKI; given ABX; respiratory status worsened requiring intubation with mechanical ventilation; ICU; sepsis; COVID pneumonia; thrombocytopenia; transfusion given pt's condition continued to decline; poor prognosis; pt passed away in the hospital
Initially (day after shot) my arm was stiff and felt some pain but went away.  8 days later I developed a rash on my body. Developed itchy rash on my breast back and armpit.  Left lymph node felt swollen. I didn?t consult doctor for 5 days and was diagnosed with shingles.  I believe it was an immune response to the vaccine. (Any vaccine so I am told). Taking anti-viral.
Exact same as first dose. 9-12 hours after dose I got severe chills. Uncontrollable.  Along with a fever up to 104.9 .   A splitting headache with very loud ringing in ears.  I used Tylenol every 6 hours to keep my fever down. It broke a few times cause extreme sweating.  I slept for 36 hours.
My ears started feeling like they had water in them similar to if you swim and have trapped water about a day to 2 days after 2nd dose,  but it has not gone away still months later. If I blow my nose my equilibrium makes me almost lose consciousness at times due to pressure in my ears.My doctor stated I had what appeared to be an infection with liquid in the ear but referred me to a Ear Nose throat specialist. Unfortunately I have medicare and no one takes that near me, so I have to travel to a doctor there, but my wife just had a baby so its been time consuming.
BRAIN FOG; STOMACHACHE; NOXIOUS BURPS; FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced brain fog, stomachache, noxious burps, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, headache, brain fog, stomachache and noxious burps was not reported. This report was non-serious.
Patient states after the second dose he was fatigued. Shortness of breath with exertion
7/13/2021: headache, sore throat, cough, shortness of breath,. admitted to the hospital 7/21/2021 dies
Redness and swelling left deltoid 3x3 cm. Localized reaction only.
Information has been received from a physician concerning a 12 month old male with no known medical history or allergies who was vaccinated SC in the right arm with a first dose of MMR II/Varicella (lot 652232/0772R). There was no illness at the time of vaccination. Subsequently, 1 day after receiving the vaccine the pt experienced high fever, 102-103 degrees and ataxia of the legs. A couple of days later the pt developed a rash on the trunk and other parts of the body. Pt outcome was not reported. Follow up information from the physician indicated that on 7/31/06 the pt in the PM had a sudden onset of fever and irritability. Several days later the pt developed a rash, loose stools and ataxia with gradual clearing by 5 days. The pts clearing was complete at 10 days. The pt recovered on 8/10/06. There were no adverse events following prior vaccination. No lab diagnostic tests were performed. The pts adverse events were considered to be disabling. Additional information is not expected.
severe left elbow pain started and eventuated in diffuse joint pains esp at the feet and ankles but also at the ant chest
chills, weakness, orthostatic hypotension Narrative:  65 yr old female called reporting fevers, chills weakness, orthostatic changes with position change, diarrhea x 18 (in the last 7hours) n/v, unable to keep fluids down, feeling very weak. Fever 102.1 currently. She had her COVID vaccine yesterday and symptoms started about 12 hours ago. Patient was actively vomiting during the call. Patient was advised to go to ED but declined due to distance and cost. No medications prescribed.
fever worst than Covid Vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Covid vaccine with an associated reaction of pyrexia.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   The reporter considered the fever to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 22-OCT-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The patient too had fever from this vaccine, it was worse than the covid vaccine. The follow-up could not be possible as no contact details were available.
Chills, sweats, migraine HA, vomiting, diarrhea.
Heart rate is high; This case was reported by a consumer via call center representative and described the occurrence of heart rate increased in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd December 2019, the patient received the 2nd dose of Shingrix. On 3rd December 2019, 1 days after receiving Shingrix, the patient experienced heart rate increased. On an unknown date, the outcome of the heart rate increased was unknown.   It was unknown if the reporter considered the heart rate increased to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient stated that after vaccination had heart rate increased. The patient asked whether increased heart rate is a side effect.
dizziness; fatigue; headache; Arm pain; Shortness of breath; Fatigue; Headache; Muscle pain; Joint pain; Chills; Nausea; This spontaneous report was reported by a consumer and describes the occurrence of   in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Blood Thinner, Flavrx Distorted Aortic Valve and CPAP Machine,  Sleep  Apnea for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The consumer reports the onset of symptoms as occurring after the first dose on 20JAN2021.These symptoms include Fatigue, Headache, Muscle Pain, Joint Pain, Chills, and Nausea. The consumer reports that these symptoms seemed to have gone away by 22-jan-2021.  On 16-Feb-2021,  the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   The consumer also reports symptoms occurring after her second dose on 17FEB2021. These symptoms include Dizziness, Fatigue, Headache, Arm Pain, and Shortness of Breath.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pfizer-BioNTech COVID-19 Vaccine EUA, Full body rash on feet, arms, legs, chest and genitals, ongoing 4 days
Patient was given 2 vaccines consecutively and immediately after both vaccines were administered, patient had a vasovagal episode. Patient was observed and symptoms improved to baseline.
Pt developed numbness, tingling, and weakness of the legs. Temporary loss of pedal dorsi-flexion bilaterally. She also had rash on face, arms, legs, and torso; along with hair loss. She was dx with transverse myelitis. 60 Day FU: continues numbness, rashes (periodic).
pt described chicken pox like rash approx 80 vesicles on trunk & low grade fever;onset was 14 days p/vax;
WEAKNESS, PRODUCTIVE COUGH WIT THICK WHITISH PHLEM, DIARRHEA, VOMITING
slight swelling in [his] face, more so in [his] neck; slight swelling in [his] face, more so in [his] neck; blood sugar level increased; ringing in [his] ears; headaches; dizziness; irregular heart rate which he also qualified as nothing severe; started coughing for a little while, for no reason, and he further described it as a dry cough; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 02Mar2021 at 11:50 (at the age of 62-year-old) as dose 1, single for COVID-19 immunization. Medical history included ongoing borderline diabetic managed it by eating well. The patient's concomitant medications were not reported. The reporter reported that the vaccination provider stated there were no side effects to the vaccine. On 02Mar2021, the patient had his blood sugar level increased to 250 range and dropped to 150, 9 hours later, around 9 pm. The patient stated his blood sugar levels never got that high, the reporter usually got as high as 180 even after a meal and usually dropped to 100, within an hour.  The reporter also added that on 02Mar2021, he experienced, ringing in his ears, headaches, dizziness, an irregular heart rate which he also qualified as nothing severe. On 02Mar2021, in night, the patient started coughing for a little while, for no reason, and it was further described as a dry cough. The reporter explained that he woke up in morning on 03Sep2021, with a slight swelling in his face, more so in his neck. The patient underwent lab tests and procedures which included blood glucose: 180 and mentioned as usually get as high as 180 even after a meal and usually drop to 100, within an hour on an unknown date, blood glucose increased to 250 range on 02Mar2021 and dropped to 150, 9 hours later,  around 9 pm on the same day and heart rate irregular on 02Mar2021. The outcome was unknown for the reported events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt saw MD 12APR995 for a hepB shot @ which time arm was reddened; returned to MD 21APR95 w/t101-102 x 24 hr; rt arm reddened area 8x10cm, edematous w/o margins; pos lymphadenopathy of rt axilla;
Worsening rash that began at local sites of immunizations on both thighs. This has happened before with the 2 previous vaccinations that child has received but the rash appears worse to mother on this event.
Pain at injection site starting evening of vaccination. Redness, swelling. Likely cellulitis. MD Rx'd prednisone. Believes vaccine aggravated arthritis.
I cannot move my left arm after the covid vaccine. It hurts to twist or move my arm. The pain is excruciating at times. It also feels lumpy all across the arm till fingers and spreading to armpits. Hand is swollen till now
Generalized itching that started within one hour of receiving vaccine  and lasted for more than 12 hours
After the first dose within 24 hours I was feeling much more sore in my left arm and I had a greater amount of fatigue that lasted for a couple of days.  The second dose was worse and I was surprised the side effects continued for about seven days. Within about 48 hours of the second dose, I was feeling pain in my arm like the first time only a little worse. The fatigue was significantly more. The fever was on again off again for seven days and ranged between 99.5 and 101.  I had bodyaches and chills. Though the chills didn't last very long, the body aches did (muscle and joint).  Throughout that entire period, I was experiencing some pretty significant nausea.  To varying degrees of intensity, the nausea  was consistent for a week.